Their number one goal of late has been to emphasise cash preservation whilst they put together their pitch to the FDA. They would be doing absolute bare bones on the other fronts and essentially waiting for the phone to ring on any cell therapy deals. It's all in on the FDA meeting for PTX-100 in the near term.
